160 related articles for article (PubMed ID: 24550071)
1. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.
Zhang C; Sturgis EM; Zheng H; Zafereo ME; Wei Q; Li G
Int J Cancer; 2014 Oct; 135(7):1615-24. PubMed ID: 24550071
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
Zhang C; Sturgis EM; Zheng H; Song X; Wei P; Jin L; Chao L; Wei Q; Li G
Int J Cancer; 2014 Apr; 134(8):1907-15. PubMed ID: 24122460
[TBL] [Abstract][Full Text] [Related]
3. Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.
Wang C; Sturgis EM; Chen X; Zheng H; Wei Q; Li G
Oncotarget; 2016 May; 7(18):26444-53. PubMed ID: 27050146
[TBL] [Abstract][Full Text] [Related]
4. Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.
Zhu L; Sturgis EM; Lu Z; Zhang H; Wei P; Wei Q; Li G
Carcinogenesis; 2017 Apr; 38(4):432-438. PubMed ID: 28334093
[TBL] [Abstract][Full Text] [Related]
5. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
Zhang Y; Sturgis EM; Li Y; Wei Q; Huang Z; Li G
Sci Rep; 2017 Jan; 7():39765. PubMed ID: 28045062
[TBL] [Abstract][Full Text] [Related]
6. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
Li Y; Sturgis EM; Zhu L; Cao X; Wei Q; Zhang H; Li G
Mol Carcinog; 2017 Apr; 56(4):1335-1343. PubMed ID: 27864908
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
[TBL] [Abstract][Full Text] [Related]
8. Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma.
Corrêa GT; Bandeira GA; Cavalcanti BG; de Carvalho Fraga CA; dos Santos EP; Silva TF; Gomez RS; Guimarães AL; De Paula AM
Oral Oncol; 2011 Sep; 47(9):888-94. PubMed ID: 21788151
[TBL] [Abstract][Full Text] [Related]
9. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G
Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
Jin L; Sturgis EM; Zhang Y; Huang Z; Wei P; Guo W; Wang Z; Wei Q; Song X; Li G
Carcinogenesis; 2013 Jul; 34(7):1551-7. PubMed ID: 23508638
[TBL] [Abstract][Full Text] [Related]
11. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.
Li F; Sturgis EM; Zafereo ME; Liu Z; Wang LE; Wei Q; Li G
Int J Cancer; 2009 Dec; 125(11):2660-5. PubMed ID: 19585505
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Lei D; Sturgis EM; Liu Z; Zafereo ME; Wei Q; Li G
Carcinogenesis; 2010 Feb; 31(2):222-7. PubMed ID: 19955391
[TBL] [Abstract][Full Text] [Related]
13. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
Wang C; Sturgis EM; Chen X; Wei Q; Li G
Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.
Wang Z; Sturgis EM; Zhang F; Lei D; Liu Z; Xu L; Song X; Wei Q; Li G
Mol Cancer; 2012 Mar; 11():17. PubMed ID: 22449259
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
Zhang F; Sturgis EM; Sun Y; Zhang Y; Wei Q; Zhang C; Zheng H; Li G
Int J Cancer; 2015 Nov; 137(10):2454-61. PubMed ID: 25976983
[TBL] [Abstract][Full Text] [Related]
17. Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population.
Singh PK; Bogra J; Chandra G; Ahmad MK; Gupta R; Kumar V; Jain A; Ali Mahdi A
Cancer Biomark; 2015; 15(2):125-31. PubMed ID: 25519014
[TBL] [Abstract][Full Text] [Related]
18. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
[TBL] [Abstract][Full Text] [Related]
19. Influential factors on tumor recurrence in head and neck cancer patients.
Matthias C; Harréus U; Strange R
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):37-42. PubMed ID: 16003553
[TBL] [Abstract][Full Text] [Related]
20. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
